Market Currents
Arena Pharmaceuticals (ARNA -3.6%) says an FDA advisory committee will meet in the second...
-
Thursday, February 2, 2012, 1:36 PM ETArena Pharmaceuticals (ARNA -3.6%) says an FDA advisory committee will meet in the second quarter to discuss the company's resubmitted application for its weight-loss drug lorcaserin. There are concerns by many analysts that lorcaserin may not be as effective as other drugs being developed.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
